Executive Summary On May 23, 2014, the United States District Court for the District of Columbia issued an opinion invalidating a final agency rule issued on July 23, 2013 (“Final Rule”) by the Health Resources and Services Administration (“HRSA”). The Final Rule had served to clarify the scope of the 340B Program’s “Orphan Drug” exclusion. …Read More
Implications of the U.S. District Court Opinion Vacating the 340B Program’s “Orphan Drug” Final Rule and Regulations
Posted on May 29, 2014 in Health Law News
Published by: Hall Render